LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000038 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
467
Total Value
$94,440.09
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 1, 2026 | Sale | 146 | $199.97 | $29,196.34 | 42,574 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 40 | $201.24 | $8,049.40 | 42,534 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 79 | $202.42 | $15,991.36 | 42,455 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 43 | $202.91 | $8,725.22 | 42,412 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 159 | $204.26 | $32,477.77 | 42,253 | Direct | โ | View Details |